Paul Willis Johns, Jr

Title: Paul Willis Johns, Jr: Innovator in Coagulation Assays

Introduction

Paul Willis Johns, Jr. is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of coagulation assays. His innovative work has led to the development of formulations that enhance the stability and efficiency of these assays.

Latest Patents

Johns holds a patent for "Ellagic acid formulations for use in coagulation assays." This invention relates to ellagic acid formulations that are highly stable for long-term storage and reduce assay time. The patent outlines a composition and method for preparing ellagic acid in a highly soluble format, which is essential for effective use in coagulation assays. The ellagic acid can be solubilized in various compounds, including sodium hydroxide, methanol, and polyether compounds such as polyethylene glycol.

Career Highlights

Johns is currently associated with Abbott Point of Care Inc., where he continues to work on innovative solutions in the medical field. His expertise in coagulation assays has positioned him as a valuable asset to the company and the industry at large.

Collaborations

Throughout his career, Johns has collaborated with several professionals, including Gordon Bruce Collier and Smitha R K Sutrala. These collaborations have further enriched his work and contributed to advancements in medical diagnostics.

Conclusion

Paul Willis Johns, Jr. is a distinguished inventor whose work in ellagic acid formulations has the potential to significantly improve coagulation assays. His contributions to the field exemplify the importance of innovation in medical diagnostics.